Literature DB >> 25778852

[Hyperviscosity syndrome].

G Dumas1, S Merceron2, L Zafrani3, E Canet4, V Lemiale5, A Kouatchet6, E Azoulay7.   

Abstract

Hyperviscosity syndrome is a life-threatening complication. Clinical manifestations include neurological impairment, visual disturbance and bleeding. Measurement of plasma or serum viscosity by a viscometer assesses the diagnosis. Funduscopic examination is a key exam because abnormalities are well-correlated with abnormal plasma viscosity. Etiologies are various but symptomatic hyperviscosity is more common in Waldenström's macroglobulinemia and multiple myeloma. Prompt treatment is needed: treatment of the underlying disease should be considered, but generally not sufficient. Symptomatic measures aim to not exacerbate blood viscosity while urgent plasmapheresis effectively reduces the paraprotein concentration and relieves symptoms.
Copyright © 2015 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Gammapathie monoclonale; Hyperviscosity syndrome; Paraprotein; Plasmapheresis; Syndrome d’hyperviscosité; Échange plasmatique

Mesh:

Year:  2015        PMID: 25778852     DOI: 10.1016/j.revmed.2015.02.005

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  A clinical picture of pulmonary embolism revealing light-chain myeloma.

Authors:  Badia Belarj; Amine El Alaoui; Souhail Dahraoui; Jean Uwingabiye; Emmanuel Millbank Owusu; Anas Rochdi; Asmaa Biaz; Abdellah Dami; Sanae Bouhsain; Zohra Ouzzif; Nawfel Doghmi; Samira El Machtani Idrissi
Journal:  Clin Case Rep       Date:  2017-11-02

2.  Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.

Authors:  Jun Li; Rui Zhang; Feng Gu; Zhe-Li Liu; Peng Sun
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

Review 3.  High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.

Authors:  Melania Carlisi; Salvatrice Mancuso; Rosalia Lo Presti; Sergio Siragusa; Gregorio Caimi
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

Review 4.  Therapeutic Plasma Exchange: For Cancer Patients.

Authors:  Yuru Hu; Hanshan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Cancer Manag Res       Date:  2022-02-02       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.